Header
Include company letterhead, ANVISA unit addressed, submission date, and the specific RDC number(s) referenced in the request or declaration.
A properly drafted Legal RDC ANVISA Letter reduces processing delays, supports regulatory traceability, and documents corporate intent for product compliance. Clear scope, correct references to the RDC numbers, and authenticated signatures help avoid requests for additional information and potential administrative rejections.
Typical users include regulatory affairs teams, in-house legal counsel, exporters, and authorized local representatives who manage Brazilian regulatory submissions.
Final signers may be company officers, designated agents, or local legal representatives; roles should be documented and match supporting authorization documents.
Include company letterhead, ANVISA unit addressed, submission date, and the specific RDC number(s) referenced in the request or declaration.
State the precise intent—registration, clarification, post-market report, or compliance attestation—and reference relevant application identifiers or protocol numbers.
Provide product name, model or SKU, active ingredients, presentation, batch or lot numbers if applicable, and any registration codes previously issued.
Include the declarative language required by the RDC, naming applicable standards, conformity claims, and citations of the regulatory text relied upon.
Provide the printed name, title, corporate authority statement, date, and an explicit statement that the signatory is authorized to bind the entity.
List accompanying documents (technical dossier, translations, notarized powers of attorney) with filenames and exhibit references for easy cross-checking.
| Field | Configuration |
|---|---|
| Document Format | Upload as PDF/A or PDF; retain originals in DOCX for edits |
| Authentication | Use email + SMS code or stronger methods for signer attribution |
| Attachments | Include translated documents and notarized exhibits as separate files |
| Retention | Enable platform retention and export signed PDF with audit trail |
Ensure your signing platform supports PDF/A export, multi-file attachments, official audit trails, and optional advanced signer authentication for regulatory records.
Choose a platform that produces a tamper-evident signed PDF with an attached certificate of completion and preserves metadata like timestamps, IP addresses, and signer attribution for audit purposes.
Typically 3–10 business days depending on complexity and available exhibits.
Allow 3–14 business days for certified translations and any notary steps.
Review duration varies widely; expect several weeks to months for substantive reviews.
Respond promptly; delays in replies commonly extend total processing time.
Retain submission proof and signed letter indefinitely per company retention policy.
Document finalized with product and RDC references; attachments listed.
Legal and regulatory sign-off obtained and recorded.
Authorized signature collected, and notarization completed if required.
ANVISA receipt or portal acknowledgment captured and archived.
A U.S. medical device firm submits a clarification letter to correct product nomenclature in its dossier.
An importer files a registration update with a power of attorney and signed RDC letter.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies by vendor | Varies by vendor | Varies by vendor | Varies by vendor |
| Bulk Send | Yes | Yes | Yes | Yes | Yes |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies | Varies | Varies |